Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 63 (RN7SKP63) is a **pseudogene**—that is, a genomically encoded sequence bearing similarity to the functional RN7SK gene, but not known to produce a functional RNA or protein product. RN7SKP63 does not code for a protein or an active non-coding RNA, and there is no evidence supporting any direct biological or therapeutic function. Its presence represents a duplication or duplication-derived remnant of the active RN7SK gene. By contrast, the functional RN7SK gene encodes a 7SK small nuclear RNA (snRNA), which is a non-coding RNA that plays a key regulatory role in transcription elongation via the 7SK ribonucleoprotein complex[1][5][3][4]. However, **RN7SKP63 itself is not a receptor, enzyme, transporter, or transcription factor**, and is not implicated in disease, drug action, or as a biomarker. **Key Notes:** - There is *nothing to suggest that RN7SKP63 is a receptor, enzyme, or valid therapeutic target*. - It is *not a functional gene*; as a pseudogene, it lacks known biological activity and is generally not transcribed or functional in cell biology[5]. - If the actual intended target was the functional 7SK RNA (RN7SK), refer to "RNA, 7SK small nuclear" for relevant molecular and biological details, not RN7SKP63[1][3][4]. - **RN7SKP63 is not a canonical molecular target.** It is likely the use of RN7SKP63 as a target is a dataset or annotation error.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 63 (RN7SKP63).